Financial Information

KemPharm® is a clinical stage, specialty pharmaceutical company engaged in the development and discovery of proprietary prodrugs that are designed to be improved versions of widely prescribed and FDA approved products.

Financial Information

Filing date Form Description Filing Group View
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
D
Other
View HTML
S-3

Simplified registration form

Registration Statements
View HTML
424B4

Form of prospectus disclosing information facts events covered in both forms 424B1 424B3

Registration Statements
View HTML
POS EX

POS EX    

Registration Statements
View HTML
S-1MEF

Registration of up to an additional 20% of securities for any offering registered on an S-1

Registration Statements
View HTML
EFFECT

EFFECT

Other
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
S-1/A

Amended Registration statement for face-amount certificate companies

Registration Statements
View HTML
8-A12B

Registration of certain classes of securities 12(b) of the Securities Exchange Act

Registration Statements
View HTML